A 72 year old man was diagnosed with chronic myelomonocytic leukaemia (CMML) according to the FAB group classification. He presented with symptoms of anaemia, urinary frequency, hesitancy, and nocturia. He was later admitted with acute urinary retention and acute renal failure, which resolved with treatment. A transurethral resection of the prostate was performed. Histological examination showed fibromuscular hyperplasia with dense infiltration by myelomonocytes which stained positively with chloroacetate esterase; immunohistochemical staining was positive for lysozyme, CD43, CD45, and CD68. Following treatment with oral etoposide he transformed to acute myeloid leukaemia and eventually died. Myelomonocytic infiltration of the prostate has not been reported before. This case extends the spectrum of disease previously recognised in CMML.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC500685 | PMC |
| http://dx.doi.org/10.1136/jcp.51.4.340 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The expression of BHLHE22 in endometrial carcinoma: Associations with mismatch repair protein expression status, tumor-infiltrating immune cells, programmed death-ligand 1 and clinical outcomes.
Taiwan J Obstet Gynecol
January 2025
Department of Pathology, Shuang Ho Hospital, Taipei Medical University, New Taipei City, 23561, Taiwan; Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, 11031, Taiwan. Electronic address:
Objective: Endometrial cancer (EC) shows substantial heterogeneity in their immune microenvironment. BHLHE22 is consistently hypermethylated in EC and high expression of BHLHE22 is likely to be immunosuppressive in the tumor microenvironment. Herein, we evaluated expression of BHLHE22, programmed cell death ligand-1 (PD-L1), CD8, CD68 and mismatch repair proteins in EC.
View Article and Find Full Text PDFRenal Proximal Tubule Cell-Specific Megalin Deletion Does Not Affect Atherosclerosis But Induces Tubulointerstitial Nephritis in Mice Fed a Western Diet.
Arterioscler Thromb Vasc Biol
January 2025
Saha Cardiovascular Research Center and Saha Aortic Center (N.A., M.K.F., M.K., L.Z., J.J.M., D.A.H., H.S., A.D., H.S.L.).
Article Synopsis
- Pharmacological inhibition of megalin in mice helps reduce atherosclerosis, but the study aimed to see if specifically deleting megalin in renal proximal tubule cells (PTCs) could have similar effects against hypercholesterolemia-induced atherosclerosis.
- The experiments involved creating mice with and without megalin (PTC-LRP2 -/-) and inducing atherosclerosis by using a Western diet, but results showed that deleting megalin did not reduce atherosclerosis in any mice.
- Instead, male PTC-LRP2 -/- mice exhibited severe kidney issues, including CD68+ cell infiltration and tubular atrophy, indicating that high-fat diets can lead to kidney damage independent of cholesterol levels, while female P
The oncogenic functions of SPARCL1 in bladder cancer.
J Cell Mol Med
November 2024
Department of Urology, Affiliated Hangzhou First People's Hospital, Westlake University School of Medicine, Hangzhou, China.
Article Synopsis
- SPARCL1, a protein from the SPARC family, is under-researched in the context of bladder cancer (BCa), leading to an exploration of its expression patterns and correlations with clinical features.
- The study found that higher levels of SPARCL1 in BCa are associated with more advanced stages of the disease and poorer patient outcomes, while in vitro tests showed that increased SPARCL1 expression can inhibit tumor cell activities.
- Moreover, SPARCL1 is linked to immune features like tumor mutation burden (TMB) and activation, suggesting a role in macrophage behavior and positioning it as a potential prognostic biomarker for BCa.
Expression of SIGLEC15 correlates with tumor immune infiltration, molecular subtypes, and breast cancer progression.
PLoS One
November 2024
Department of Pathology, Zhongnan Hospital of Wuhan University, Wuhan, P. R. China.
Breast cancer (BRCA) is among the most prevalent cancers and is responsible for numerous patient fatalities. Immunotherapy has emerged as a promising approach to cancer treatment. Recent studies have identified Siglec-15 as a novel immune target that plays a crucial role in tumor immune evasion, suggesting its potential significance in BRCA.
View Article and Find Full Text PDF[Infarction and splenic abscess as the cause of acute abdomen in a patient with myelomonocytic leukemia].
Rev Med Inst Mex Seguro Soc
May 2024
Instituto Mexicano del Seguro Social, Centro Médico Nacional La Raza, Hospital de Especialidades "Dr. Antonio Fraga Mouret", Servicio de Cirugía General, Departamento de Cirugía Hepatobiliar y Pancreática. Ciudad de México, México.
Background: Splenic infarction is a rare cause of acute abdomen. The two main causes are thromboembolic diseases and infiltrative hematological disorders. The splenic abscess is the result of a hematogenous seeding, whose causes are trauma, splenic artery embolization, endocarditis, and immunocompromised states.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!